Evidence map›Paper›PMID 38786735›Full record

ArticleMetabolites2024

Prediction of Myocardial Infarction Using a Combined Generative Adversarial Network Model and Feature-Enhanced Loss Function.

Shixiang Yu, Siyu Han, Mengya Shi, Makoto Harada, Jianhong Ge, Xuening Li, Xiang Cai, Margit Heier, Gabi Karstenmüller, Karsten Suhre and 5 more

Abstract read
In one paragraph

Article in Metabolites, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. An explainable machine learning approach to predicting carbapenem resistance inFrontiers in cellular and infection microbiology · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Shixiang YuTUM School of Medicine and Health, Technical University of Munich, 81675 München, Germany.ORCID 0000-0002-7065-9754
Siyu HanTUM School of Medicine and Health, Technical University of Munich, 81675 München, Germany.ORCID 0000-0001-8709-5564
Mengya ShiTUM School of Medicine and Health, Technical University of Munich, 81675 München, Germany.
Makoto HaradaInstitute of Translational Genomics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.ORCID 0000-0002-6209-7683
Jianhong GeTUM School of Medicine and Health, Technical University of Munich, 81675 München, Germany.ORCID 0009-0003-2142-9084
Xuening LiBiocomputing R&D Department, Beijing Huanyang Bole Consulting Co., Ltd., Beijing 100010, China.
Xiang CaiSchool of Computer Science and Information Security, Guilin University of Electronic Technology, Guilin 541214, China.
Margit HeierKORA Study Centre, University Hospital of Augsburg, 86153 Augsburg, Germany.ORCID 0000-0002-7317-7566
Gabi KarstenmüllerInstitute of Computational Biology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Karsten SuhreDepartment of Physiology and Biophysics, Weill Cornell Medicine and Director of the Bioinformatics Core, Doha 24144, Qatar.ORCID 0000-0001-9638-3912
Christian GiegerResearch Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.
Wolfgang KoenigDeutsches Herzzentrum München, Technische Universität München, 80636 München, Germany.ORCID 0000-0002-2064-9603
Wolfgang RathmannInstitute for Biometrics and Epidemiology, German Diabetes Center, Leibniz Center for Diabetes Research, Heinrich Heine University, 40225 Düsseldorf, Germany.
Annette PetersInstitute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.ORCID 0000-0001-6645-0985
Rui Wang-SattlerInstitute of Translational Genomics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764 Neuherberg, Germany.ORCID 0000-0002-8794-8229

Funding

Innovative Medicines Initiative 2 Joint Undertaking (JU) 821508 (CARDIATEAM)the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria KORAthe German Federal Ministry of Health (Berlin, Germany) and the Ministry of Science and Culture in North-Rhine Westphalia (Düsseldorf, Germany). DZD
6 · The paper itself

Abstract

Accurate risk prediction for myocardial infarction (MI) is crucial for preventive strategies, given its significant impact on global mortality and morbidity. Here, we propose a novel deep-learning approach to enhance the prediction of incident MI cases by incorporating metabolomics alongside clinical risk factors. We utilized data from the KORA cohort, including the baseline S4 and follow-up F4 studies, consisting of 1454 participants without prior history of MI. The dataset comprised 19 clinical variables and 363 metabolites. Due to the imbalanced nature of the dataset (78 observed MI cases and 1376 non-MI individuals), we employed a generative adversarial network (GAN) model to generate new incident cases, augmenting the dataset and improving feature representation. To predict MI, we further utilized multi-layer perceptron (MLP) models in conjunction with the synthetic minority oversampling technique (SMOTE) and edited nearest neighbor (ENN) methods to address overfitting and underfitting issues, particularly when dealing with imbalanced datasets. To enhance prediction accuracy, we propose a novel GAN for feature-enhanced (GFE) loss function. The GFE loss function resulted in an approximate 2% improvement in prediction accuracy, yielding a final accuracy of 70%. Furthermore, we evaluated the contribution of each clinical variable and metabolite to the predictive model and identified the 10 most significant variables, including glucose tolerance, sex, and physical activity. This is the first study to construct a deep-learning approach for producing 7-year MI predictions using the newly proposed loss function. Our findings demonstrate the promising potential of our technique in identifying novel biomarkers for MI prediction.

Indexed as

feature enhancementGAN for feature-enhancedgenerative adversarial networksGFE loss functionlimited and imbalanced incident casesmyocardial infarctionprediction

Identifiers

PMID38786735
PMCPMC11122941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.